NCT00754091

Evaluate Retention of an Orally Administered Device Using Gamma Scintigraphy

Retention of an Orally Administered Investigational Device in the Oropharynx of Healthy Human Male Volunteers

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 16 (actual)
• Sponsor: Procter and Gamble · Industry
• Sex: Male
• Age: 18 Years – 40 Years
• Healthy volunteers: Accepted

Summary

Single usage, open label study in 16 adult healthy males. Eligible subjects will receive a single usage of the investigational device. Retention of the radiolabeled device will be monitored using gamma scintigraphy.

Conditions

• Healthy Subjects

Interventions

Type	Name	Description
DEVICE	Polymer based lubricating liquid	three sprays of radiolabeled polymer blend of carboxymethylcellulose, polyoxyl 40 stearate, and polyethylene oxide that coats and protects the mucus membrane

Timeline

• Start date: 2008-06-01
• Primary completion: 2008-06-01
• Completion: 2008-06-01
• First posted: 2008-09-17
• Last updated: 2019-03-26

Locations

1 site across 1 country: United States